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Abstract
Recent data demonstrates that stem cells can exist in two morphologically, molecularly and functionally distinct pluripotent
states; a naı¨ve LIF-dependent pluripotent state which is represented by murine embryonic stem cells (mESCs) and an FGF-
dependent primed pluripotent state represented by murine and rat epiblast stem cells (EpiSCs). We find that derivation of
induced pluripotent stem cells (iPSCs) under EpiSC culture conditions yields FGF-dependent iPSCs from hereon called FGF-
iPSCs) which, unexpectedly, display naı¨ve ES-like/ICM properties. FGF-iPSCs display X-chromosome activation, multi-lineage
differentiation, teratoma competence and chimera contribution in vivo. Our findings suggest that in 129 and Bl6 mouse
strains, iPSCs can dominantly adopt a naive pluripotent state regardless of culture growth factor conditions. Character-
ization of the key molecular signalling pathways revealed FGF-iPSCs to depend on the Activin/Nodal and FGF pathways,
while signalling through the JAK-STAT pathway is not required for FGF-iPS cell maintenance. Our findings suggest that in
129 and Bl6 mouse strains, iPSCs can dominantly adopt a naive pluripotent state regardless of culture growth factor
conditions.
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Introduction
Pluripotent stem cells are characterized by their ability to
expand indefinitely in vitro while retaining the capacity to generate
derivatives of all three germ layers, both in vitro and in vivo. Sources
of pluripotent stem cells include blastocyst embryos, which give
rise to embryonic stem cells (ES cells), and the post-implantation
epiblast which gives rise to epiblast stem cells (EpiSCs) [1,2].
ES cells and EpiSCs are both pluripotent as they are capable of
generating derivatives of the three embryonic germ layers upon in
vitro or in vivo differentiation, yet important molecular and
functional differences exist between these two pluripotent states.
At the molecular level, the ES cell pluripotent state is maintained
by a combination of LIF/JAK/STAT3 and BMP4 signaling,
while EpiSCs require a combination of bFGF and TGFb/Activin
signaling for their continued self-renewal. The different culture
conditions that maintain ES cells and EpiSCs are reflected in the
morphological, molecular and functional properties of these cells.
Murine ES cells form dome-shaped three dimensional colonies
and are capable of generating chimeras with functional contribu-
tion to all somatic lineages as well as the germline. In contrast,
EpiSCs form flatted colonies that are split by mechanical- or
collagen-mediated passaging as small clusters of cells, since EpiSCs
cannot be passaged as single cells by trypsin digest. EpiSCs are
pluripotent and form derivatives of all three germ layers during in
vitro differentiation and upon teratoma formation in vivo. Unlike
ES cells, EpiSCs can even generate trophoectoderm derivatives in
vitro. Yet, fail to integrate with the ICM upon morula aggragation
and as a result, chimera forming potential of EpiSCs is very low or
even absent. Thus, while EpiSCs are pluripotent, to-date their in
vivo developmental potential is limited to teratoma formation.
Above results demonstrate that in the mouse, two functionally
distinct pluripotent states exist, a naı¨ve LIF-dependent pluripotent
state that is compatible with the pre-implantation ICM and a
primed FGF-dependent state that is reminiscent of the post-
implantation epiblast [3].
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The ability to generate ES cell lines is restricted to only a few
inbred mouse strains whereas other, so-called ‘‘non-permissive’’
mouse strains fail to yield ES cells under standard culture
conditions, but instead can give rise to to EpiSCs,Pluripotent
stem cell lines from other species, including human and rat, share
many of the defining characteristics of EpiSCs, suggesting that the
EpiSC pluripotent state is the common stable pluripotent state for
most strains of mice as well as other species. Interestingly, Hanna
and colleagues recently demonstrated that the constitutive ectopic
expression of either Klf4 or cMyc allows the derivation of LIF-
dependent ES-like cells from blastocyst embryos of the non-
permissive NOD mouse strain [4]. In addition, LIF/serum-
dependent ES-like cell lines can be generated through somatic cell
reprogramming of NOD fibroblasts with defined factors (Oct4,
Sox2, Klf4, cMyc) that have recently been shown to allow the
generation of induced pluripotent stem cells (iPS cells) from
somatic cells [5,6]. Yet, as with the blastocyst-derived NOD ES
cell lines, the stable propagation of NOD iPS cells is dependent on
the continued ectopic expression of Klf4 or cMyc.
Small molecule inhibitors of glycogen synthase kinase beta
(GSK3b) and the mitogen-activated protein kinase (MAPK)
signaling pathway can replace some of the reprogramming factors
during iPS cell generation [7], and these inhibitors can similarly
stabilize the LIF/serum-dependent pluripotent state in blastocyst-
derived stem cells or iPS cells from the the non-permissive NOD
mouse strain [4,8,9,10]. Thus, it appears that the LIF-dependent
pluripotent state is metastable in NOD mice, meaning it is
dependent on either the constitutive expression of ectopic
reprogramming factors or the presence of small molecule
inhibitors of the GSK3b and/or the MEK/ERK signaling
pathway. In the absence of these exogenous factors, NOD iPS
cells assume a stable EpiSC-like state, even when LIF is present in
the culture media.
Genetic background appears to play an important role in
stabilizing the LIF-dependent pluripotent state, yet its role in
defining the FGF-dependent pluripotent stateis less clear. We
explored the possibility of generating EpiSCs by iPS reprogram-
ming of murine embryonic fibroblasts from the permissive129
and/or BL6 mouse strains in EpiSC culture conditions.
Unexpectedly, we found that even in the presence of EpiSC
culture conditions, iPS cells adopt a naive ICM/ES-like
pluripotent state. Thus, it appears that strain-specific genetic
elements dictate that in permissive mouse strains, the ES-like
pluripotent state is dominant following iPS reprogramming
Results
Generation and molecular analysis of FGF-iPSCs
Murine embryonic fibroblasts (MEFs) of E14 Oct4-GFP (BL6/
tgOct4-GFP) were transduced with a cocktail of retroviruses
expressing the iPS reprogramming factors (Oct4, Sox2, Klf4 and
c-Myc) as shjown schematically in (Figure 1A). Upon transduction,
the cells were passaged with trypsin and then re-plated onto a
feeder layer of mitotically inactivated MEFs. From day 7 onwards,
infected fibroblasts were maintained in bFGF medium (DMEM,
20% Serum Replacement and 4 ng/ml bFGF). Starting from days
10–12, we observed the emergence of tightly compact colonies,
which had reactivated the Oct4-GFP transgene (Figures 1B–1E).
On day 17, single colonies were picked, and further propagated in
bFGF medium. Unexpectedly, upon subsequent passaging, the
cultures uniformly maintained a characteristic murine ES-like
morphology, with round and compacted cell clusters expressing
Oct4-GFP (Figures 1F–1I) which contrasts sharply with the
flattened two-dimensional colony morphology of EpiSCs derived
and maintained under the same culture conditions. We name
these cells mouse FGF-iPSCs, to distinguish them from conven-
tional LIF-dependent murine ESCs and iPSCs. In addition to the
ES-like morphology, FGF-iPSCs cultures exhibited homogeneous
SSEA-1, but not SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81
expression (Fig. 1H, I). In addition, FGF-iPSCs reactivate
endogenous Oct4-GFP, Sox2 and Nanog (Fig. 1J–Q, Figure S1).
Cytogenetic analysis of two independent FGF-iPS cell lines
revealed a normal karyotype (2n= 40) even after prolonged
culture at high passage number (passage 28, 3 months in culture)
(Fig. S1C and data not shown). As expected, bisulfite sequencing
demonstrated hypomethylation of the Oct4 promoter region as
tested in 12 different CpG islands scattered around 350 bp of the
Oct4 minimal promoter (Fig. S1A). Correct establishment of the
reprogrammed cell state was confirmed by complete silencing of
the exogenous reprogramming factors as revealed by qPCR
(Figure S1B).
Growth factor culture conditions affect the dynamic of
iPS reprogramming
To examine the effect of the growth factor conditions on the
dynamic of the iPS reprogramming response, we reprogrammed
from 129/BL6 F1 embryonic fibroblasts either in the presence of
LIF/serum (standard murine ES/iPS conditions) or in the
presence of bFGF (EpiSC conditions). For this purpose, we
employed the recently reported STEMCCA inducible lentiviral
vector system, which allows the expression of the four reprogram-
ming factors (Oct4, Sox2, Klf4 and cMyc) from a single lentiviral
vector in a doxycyclin-inducible manner through the action of the
reverse tetracycline transactivator (rtTA) at high efficiency (Figure
S2A) [11]. Figure 2A schematically displays the experimental
setup. Murine embryonic fibroblasts were transduced with the
doxycyclin-inducible reprogramming factors and rtTA and
reprogramming was induced 24 hours after infection (t = 0). At
day 1, the sample was split and cells were cultured either in the
presence of LIF (mES conditions) or in the presence of bFGF
(EpiSC conditions). At set time intervals (between day 5 and day
15), ectopic reprogramming factors were silenced by removal of
doxycycline. Colonies were visualized by Crystal Violet staining on
day 18. After approximately 10–12 days, iPS colonies appeared
under both conditions, and the LIF-derived iPS cells displayed a
characteristic ES-like colony morphology, whereas we noted iPS
cells derived in the presence of bFGF displayed the characteristic
flattened colony morphology of EpiSCs (Figure S2B). However,
the EpiSC-like colonies were unstable, and upon withdrawal of the
ectopic reprogramming factors, most of the EpiSC-like iPS cells
assumed a fibroblast-like morphology, indicating that they were
partially reprogrammed and had not activated their endogenous
pluripotency program. Indeed, the Oct4-GFP reporter gene
present in these cells was not reactivated in the EpiSC-like iPS
cells, whereas the control iPS cells did reactivate Oct4-GFP (not
shown). However, in the FGF conditions, few colonies remained
after silencing of ectopic reprogramming factors, which could be
stably propagated in the presence of bFGF, and yet displayed the
characteristic murine ES-like colony morphology. The number of
stable FGF-iPS colonies increased with longer reprogramming
time, but lagged behind compared to the LIF control iPS cells. As
shown in figure 2B, in the presence of bFGF, stable iPS colonies
emerged after 9 days of doxycycline-induced reprogramming,
whereas in the presence of LIF, stable colonies were noted 4 days
earlier.
Thus, it appears that while the culture growth factor conditions
affect the dynamic of the iPS reprogramming process, with stable
colonies emerging late under FGF growth factor conditions, the
Generation of Mouse FGF-iPS Cells
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general outcome of the reprogramming response is not affected by
the culture conditions.
FGF-iPSCs display molecular and epigenetic features of
the ICM/ES cell pluripotent state
The emergence of iPS cell colonies with typical murine ES-like
characteristics under EpiSC culture conditions was unexpected
and hence we performed genome-wide expression analysis to
further characterize these cells. As shown in Figure 3A, FGF-
iPSCc display a gene expression pattern characteristic of murine
ES cells, including the inner cell mass markers Rex1, Nanog,
Oct4, Sox2, Sall4, Gdf3 and Eras. In contrast, typical EpiSC
markers, including FGF5, Eomes (also known as Tbr2), FoxA2
and Cer1 were not expressed in FGF-iPSCs (Fig. 3A). Microarray
data were confirmed by qPCR expression analysis (the list of used
primers is available in table S1) (Fig. 3C). Hierarchical cluster
analysis of the global gene expression profiles of FGF-iPSCs cells,
LIF-derived iPS cells, murine ESCs and EpiSCs revealed that
FGF-iPSCs are highly similar to murine ES- and LIF-derived iPS
cells, whereas EpiSCs cells form a separate cluster of unrelated
cells (Fig. 3B). Starting fibroblasts are absent in this analysis as
most of the investigated were not expressed in the cells prior to
iPSC reprogramming.
Alkaline phosphatase (AP) is a widely used marker distinguish-
ing murine ESCs, which are expressing AP, from EpiSCs, which
are negative for this marker. Interestingly, iPSCs derived in the
presence of bFGF were strongly positive for the AP staining,
further confirming their similarity to ESCs (Fig. 4A, B).
In addition to the above molecular and morphological
characteristics, we examined the epigenetic properties of the
FGF-iPSCs. The pluripotency mediator Oct4 is differentially
expressed from two distinct enhancer regions; a distal enhancer
Figure 1. Generation of FGF-iPS from mouse fibroblasts by retroviral transduction. Schematic diagram illustrating a timetable of the
critical steps of the reprogramming protocol utilized. Embryonic mouse fibroblasts were transduced with retroviruses carrying Oct4, Sox2 Klf4 and c-
Myc and then transferred onto MEF feeder layers in DMEM medium supplemented with 10% FBS. After 4 days the medium was switched to a human
ESC culture medium. Colonies activated the Oct4-GFP transgene after twelve days in culture (B–C) and are isolated for expansion after 17–18 days (D–
E). After picking, single clones give rise to stable cell lines of FGF-iPSCs, which grow as round compacted colonies (F, H) expressing the Oct4-GFP
transgene (G, I). Colonies expressing the Oct4-GFP (K, O, S) result positive for alkaline phosphatase activity (AP) (J), and SSEA-1 (M), Sox2 (P) and
Nanog (T) immunoistochemistry. Merged figures for Sox2/Oct4-GFP and Nanog/Oct4- immunostainings are showed in Q and U, respectively. DAPI
fluorescent staining is labeling cell nuclei (blue) in L, N, R.
doi:10.1371/journal.pone.0016092.g001
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which drives Oct4 expression in murine ES cells and and a
proximal enhancer which mediates Oct4 expression in EpiSCs
[12]. Thus, Oct4 enhancer choice is a distinctive feature between
ES cells and EpiSCs. As shown in Figure S1D, Oct4 expression is
driven by the ES-specific distal enhancer in FGF-derived
iPS cells, as well as the ES- and LIF-derived iPS controls. In
contrast, as expected, the proximal enhancer is active in control
EpiSCs.
In addition, we examined the X-inactivation state of iPSC
clones from a female cell line by RNA FISH for Xist. As
demonstrated in Figure 4C–D the majority of FGF-iPSCs contains
two active X chromosomes as demonstrated by the presence of
only basal (pinpoint) Xist expression on both X chomosomes as
also observed in the mESC control cells (Figure 4C) whereas in
some cells an Xist-cloud was observed (Figure 4C, arrow). As
expected, FGF-iPSCs robustly display X-inactivation upon
differentiation, demonstrating that the cells are capable of X-
inactivation (Figure 4C). The percentage of FGF-iPSCs containing
a Xist-cloud is quantified in Figure 4D and demonstrated that
approximately 90% of the undifferentiated FGF-iPSCs contain
two active X-chromosomes, whereas 40% of the FGF-iPSCs
display X-inactivation after 4 days of differentiation. The
percentage of FGF-iPSCs displaying an Xist-cloud (10%) is higher
than X-inactivation observed in control mESCs (0.5%) and is
perhaps reminiscent of the higher percentage of X-inactivation
also observed in human ESCs. Finally, immunofluorescence-based
detection of the trimethylated H3 lysine 27 (me3H3K27), a
repressive histone modification, revealed the absence of a silent X
chromosome in two undifferentiated female FGF-iPS cell lines
(Fig. 4E). This is in stark contrast to EpiSCs which exhibit
complete X-chromosome inactivation similar to their tissue of
origin. Together these data demonstrate that in addition to
morphological and molecular similarities, FGF-iPSCs display an
epigenetic profile characteristic of mESCs as well.
Murine FGF-iPSCs are FGF-dependent
Despite the common expression of pluripotency genes between
LIF or FGF derived iPSCs, important differences emerged in the
expression levels of genes encoding key factors of the Nodal/
Activin or Jak/Stat3 pathways between the two cell types. In fact,
FGF-iPSCs exhibited high expression levels of Nodal and Inhba
and, simultaneously, a low expression of genes downstream of the
LIF-JAK-STAT3 signalling pathway (Stat3, Jak1, Jak2 and Pim1)
in comparison to conventional ESCs and iPSCs as detected by
microarray profiling and confirmed by qPCR analysis (Fig. 5A, B).
To confirm that FGF-iPS are maintained independent of JAK-
STAT3 signaling, we cultured FGF-iPSCs in the presence of a
JAK inhibitor (JAKi) or a LIF blocking antibody, in order to
inhibit Stat3 phosphorylation (Fig. 6A). As shown in Figure 6G,
addition of the JAKi inhibitor efficiently eliminates STAT3
phosphorylation under these conditions both in FGF-iPS and
conventional mESCs, in which STAT3 is robustly activated. FGF-
iPSCs could be propagated for more than 7 passages in the
presence of JAKi inhibitor while maintaining their undifferenti-
ated state and Oct4-GFP endogenous expression (Fig. 6B, C). In
contrast, we observed rapid loss of pluripotency gene expression
when conventional mouse ESC and/or iPSC were cultured under
the same conditions (Fig.6). Furthermore, these cells displayed a
strong AP activity and lacked any evident me3H3K27 staining
ruling out the induction of Epi-like stem cells in these conditions
(Fig. 6D–F). Accordingly, FGF-iPSCs maintained for 5 passages in
the presence of JAKi inhibitor, retained their characteristic ESC-
like gene expression profile with expression of ESC-like markers
Stra8, Rex1 and Stella (Dppa3) and absence of epiblast marker
expression (Cer1, Dkk1 and FGF5) (Fig. 6H). Conversely,
inhibition of TGFbeta/Activin signaling using a specific inhibitor
of the type I Activin receptor (ALK-I) resulted in rapid FGF-iPSC
differentiation, while this inhibitor did not affect mESC self-
renewal (Fig. 6). Control EpiSCs and human ESCs similarly
Figure 2. Derivation of murine iPS cells in the presence of bFGF by inducible lentiviral transduction. (A) Schematic representation of the
strategy used for the reprogramming of murine fibroblasts into iPS cells in the presence of LIF or bFGF. (B) Image of an EpiSC-like iPS cell colony
derived in bFGF. (C) Schematic of the temporal analysis of the emergence of stable iPS colonies in the presence of bFGF. At day -1, murine embryonic
fibroblasts are infected with the doxycycline-inducible reprogramming factors and rtTA. AT day 0, doxycycline is added to the culture media to
initiate expression of the ectopic reprogramming factors. On day 1, the sample is split into dishes which are subsequently maintained in the presence
of LIF or bFGF. Starting at day 5, doxycycline is withdrawn at set time intervals and emergence of stable, factor-independent colonies is analyzed at
day 18. (D) Emergence of stable, factor independent colonies upon iPS reprogramming in the presence of bFGF (top panel) or LIF (bottom panel).
Indicated on top is the day at which doxycycline was withdrawn from the culture to silence the ectopic reprogramming factors.
doi:10.1371/journal.pone.0016092.g002
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differentiated upon ALK-1 inhibition (data not shown). In
addition, FGF withdrawal or FGF receptor inhibition by the
application of SU5402 in FGF-iPSCs for six days resulted in
widespread cell death (Figure S3). These findings demonstrate that
FGF-iPSCs are maintained independent of the activation of the
JAK-Stat3 signalling pathway. Instead, FGF-iPSC self-renewal
relies on the continued presence of FGF stimulation and activity of
the TGFbeta/Activin signaling cascade.
Indeed, downstream mediators of FGF- and TGFbeta/Activin
signaling are activated in FGF-iPSCs., We assessed Smad 2/3,
Smad 1/5/8 levels in mouse ESCs, LIF-iPSCs and FGF-iPSCs by
Western blot analysis. ESCs and LIF-iPSCs showed phosphory-
lation of Smad 1/5/8, indicating active transduction of Bmp
signaling (Fig. 5C). On the contrary, two independent FGF-iPSC
lines displayed a strong activation of Smad 2/3 concomitant with
undetectable levels of Smad 1/5/8 active forms (Fig. 5C). qPCR
analysis confirmed that specific to FGF-iPSCs, Bmp4 expression
was significantly down-regulated together with the up-regulation
of Gdf3 and Gremlin-1 (Grem1), two well-known Bmp4
antagonists [13,14,15] (Fig. 5B). Taken together, these findings
demonstrate that self-renewing FGF-iPSCs exhibit activation of
FGF and TGFbeta/Activin downstream signaling pathways and
undetectable BMP4 signalling, in contrast to mESCs, in which the
BMP4 signalling pathway is prominently activated and TGFbeta/
Activin signalling is low (Fig. 5D).
Next, to definitively exclude the role of feeder cells in promoting
FGF-iPS stem cell properties, we serially cultured FGF-iPSCs on
fibronectin-coated plates in the absence of fibroblast feeder cells. At
passage 6, corresponding to 5 weeks of culture in these conditions,
FGF-iPS colonies revealed strong Oct4-GFP and Nanog endogenous
expression as well as evident AP activity (Fig. 7A–G). In contrast,
FGF-iPSCs did not show inactivation of the X-chromosome as
indicated by lack of me3H3K27 staining (Fig. 7H). In line with these
findings, FGF-iPSCs expressed Nanog, Rex1 and Stella (Dppa3) at
similar levels to those detected when cultured on feeder conditions,
and the EpiSCmarkers Cer1 and FGF5 were not found up-regulated
Figure 3. The ES-like pluripotent state is dominant in the 129/BL6 genetic background. (A) Comparative gene expression analysis among
conventional murine ESCs, LIF-iPSCs, FGF-iPSCs and EpiSCs for candidate genes of pluripotency. Normalized expression intensity values (scaled
median ratio) were obtained from Agilent whole-genome microarrays. Two biological replicates were used for all cell types. (B) Unbiased cluster
analysis of global gene expression profiles of two independent FGF-derived iPS clones, two independent LIF-derived-iPS clones, two murine ES cell
lines and two EpiSC cell lines. (C) qPCR quantification of the pluripotency associated genes Nanog, Sox2, Oct4, Rex1, Fbx15, Eras, Cripto, Cer1, Daz1,
Fgf5, Sox17, Dkk1 and Lefty1 in LIF-iPSCs compared to FGF-iPSCs.
doi:10.1371/journal.pone.0016092.g003
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as tested by qPCR (Fig. 7I). Interestingly, expression of the STAT3-
induced gene Socs3 was strongly reduced suggesting that this
signaling is generally repressed in these culture conditions (Fig. 6I).
Thus, FGF-iPSCs conserved those cardinal molecular and epigenetic
features closely associated to pluripotency even when deprived of
feeder layers for prolonged time.
To test the influence of the growth factor milieu on pluripotency
of FGF-iPS cells, we examined the effect of LIF stimulation on
Figure 4. FGF-iPSCs do not share crucial properties of EpiSCs. (A) Colony morphology of FGF iPSCs (left), murine ES cells (middle) and EpiSCs
(right). Note the dome-shaped, three dimensional morphology of the FGF-iPS cells. (B) Alkaline phosphatase (AP) staining of the cells in (A). FGF-iPSCs
are expressing AP at levels comparable with murine ESCs. On the contrary EpiSCs are negative for this markers. (C) FISH analysis show that the
majority of FGF-iPSCs contains two active X chromosomes. FGF-iPSCs robustly display X-inactivation upon differentiation. The percentage of FGF-
iPSCs containing a Xist-cloud is quantified. (D) Approximately 90% of the undifferentiated FGF-iPSCs contain two active X-chromosomes, whereas
40% of the FGF-iPSCs display X-inactivation after 4 days of differentiation. (E) Double immunostaining for me3H3K27 and Oct4-GFP in two female
FGF-iPS cell lines. Differentiated cells which lost Oct4 expression show an evident me3H3K27 positive nuclear staining corresponding to the
inactivated X-chromosome (arrow). On contrary, undifferentiated Oct4-GFP+ cells do not present any me3H3K27 positive nuclear puncta. White arrow
indicates the diagnostic staining for the inactive X chromosome. Inset in D is a higher magnification of a single cell nucleus with a me3H3K27 positive
inactivated X-chr.
doi:10.1371/journal.pone.0016092.g004
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these cells. Upon culture for 10 days in a traditional mouse ESC
culture medium (20% Serum, LIF), the vast majority of FGF-
iPSCs were rapidly induced to differentiate causing the fragmen-
tation of the colonies into numerous polygonal-shaped GFP-
isolated cells (data not shown). However, few cells tightly adherent
in small colonies maintained a strong Oct4-GFP expression. Upon
trypsinization into single cells and propagation on MEFs, these
cells organized into typical mouse ESCs colonies, a morphology
maintained even after extensive expansion (P10, 6 weeks in
culture) (Figure S4A–D). We termed these cells ‘‘LIF stimulated
FGF-iPSCs’’ to indicate their FGF-iPSC origin. The conversion
efficiency was approximately ,0.01% comparable process to the
recently reported conversion of EpiSCs into mESC-like cells [16].
Furthermore, when culture conditions were switched back to the
original FGF culture medium, the cells re-acquired all the FGF-
iPSC morphological characteristics (Figure S4E, F). These results
emphasize once again that FGF-iPS cells do not depend on LIF
signals for their continued self-renewal, but instead differentiate
when switched to LIF culture conditions. However, similar to the
recently reported conversion of EpiSCs into mESC-like cells, a
small fraction of FGF-iPSCs can adapt to the LIF culture
conditions and convert into a mESC-like state.
Murine FGF-iPSCs generate chimeras with germline
transmission
To determine the developmental potential of FGF-iPSCs, we
examined their in vitro and in vivo differentiation. We generated
aggregates, termed embryoid bodies (EBs), in which pluripotent
stem cells differentiate in a manner closely resembling early
embryonic development, with the formation of early derivatives of
the three embryonic germ layers and downregulation of
pluripotency genes. Indeed, we observed rapid loss of Oct4-GFP
expression in FGF-iPSC-derived EBs after 4 days of differentiation
(Fig. 8A). EBs plated onto matrigel coated dishes in serum-free
medium containing bFGF differentiated into Nestin expressing
neuronal cells (ectoderm) (Fig. 8B). When these EBs were
incubated on gelatin-coated tissue culture plates in DMEM
medium supplemented with 10% FBS for 15 to 20 days, they
differentiated into a wide range of cell types including Sox17
positive endoderm progenitors and Sma positive smooth-muscle
cells (mesoderm) (Fig. 8C, D).
To test pluripotency in vivo, FGF-iPSCs were injected subcuta-
neously into nude mice. Six weeks after transplantation, teratomas
were isolated and histological analysis confirmed the presence of
well defined differentiated derivatives of the three embryonic germ
Figure 5. FGF-iPSCs show activation of opposite TGFb and FGF intracellular pathways with respect to ESCs and LIF-iPSCs. (A) Heat-
map diagram of a small selection of self-renewal related genes that are in common between the three cell types. Shown are genes which are part of
the pluripotency machinery, primitive-streak, Jak-Stat pathway and TGFb signaling pathway. (B) qPCR analysis for mRNA level quantification of the
Nodal, Inhba, Bmp4, Gremlin-1 (Grem1) and Gdf3 genes in FSR-iPSCs and ESCs. (C) Immunoblotting showing the phosphorylation levels of the
different SMAD and ERK1/2 proteins and compared among ESCs, LIF-iPSCs and FSR-iPSCs, tested as protein extracts of cell cultures grown in their
normal conditions. In some conditions FGF-2 (bFGF) was withdrawn for six days. (D) General outline illustrating the state of activation of the
two different molecular branches of the TGFb signaling and their key molecular components in FSR-iPSCs and LIF dependent stem cells (ESCs and
LIF-iPSCs).
doi:10.1371/journal.pone.0016092.g005
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layers, including neural tissue, adipose tissue, epithelial structures
and muscle fibers (Fig. 8E–H).
The most important functional difference between mESCs and
EpiSCs is the striking inability of EpiSCs to form chimeras upon
morula or blastocyst injection [1,2]. We examined the ability of
FGF-iPS cells to integrate into preimplantation stage mouse
embryos by aggregating mouse embryos at the 8 cells or morula
stage with clumps of FGF-iPSC. GFP-positive FGF-iPSCs readily
integrated with the developing inner cell mass and chimeric
animals were successfully obtained at a frequency of approxi-
mately 24% (11 chimeras out of 46 animals) with a coat-color
contribution ranging between 5% to 80% (Fig. 7I,L). Further-
more, germline transmission was obtained from two chimeras,
derived from two independent FGF-iPSC lines (#5 and #9), as
revealed by coat color and confirmed by the presence of the Oct4-
GFP transgene in the offspring (Fig. 8M, N). These results
demonstrate that the developmental potential of FGF-iPSCs is
comparable to that normally exhibited by conventional LIF-
dependent ESCs and iPSCs and FGF-iPSCs can functionally
contribute to chimera formation.
We did not test the ability of FGF-iPSCs to generate entirely
iPSC-derived mice by tetraploid blastocyst complementation, but
analysis of the Dlk1-Dio locus revealed that in at least one FGF-
iPSC clone the expression of Gtl2 was correct (Figure S5),
demonstrating that similar to LIF-dependent iPSCs, the imprint
status of this locus is not always preserved, but some clones can be
identified that show a correct imprint status.
Discussion
Together, our data demonstrate that derivation of stable iPS
cells in the presence of bFGF yields two types of colonies. Colonies
with morphological characteristics of EpiSCs, which are unstable
and remain dependent on the constitutive expression of ectopic
reprogramming factors. These are likely partially reprogrammed
colonies, since they fail to reactivate endogenous pluripotency
genes. In addition, stable, ectopic factor-independent colonies
emerge, which display morphological, molecular, epigenetic and
functional properties of murine ES cells. These murine FGF-iPSCs
are maintained in an FGF-dependent fashion (.40 passages) with
a normal karyotype, and display multilineage differentiation in vitro
and broad developmental potential in vivo, including the
generation of germline competent chimeras.
Together our results demonstrate that while the growth factor
conditions influence the dynamic of the somatic cell reprogram-
ming response, the ES-like pluripotent state is the dominant
Figure 6. Effect of Jaki, ALKi and LIF-antibody on FGF-iPSCs and LIF dependent ES and iPS cells. (A) All cell samples were plated onto
inactivated MEFs and treated for one week with Jaki, Alki or LIF-blocking antibody to evaluate the dependency from LIF/Stat pathway or TGFb
pathway. The percentage of persisting Oct4-GFP positive colonies was evaluated at day 7. Reported values were normalized over the internal control
(number of colonies in growth medium without inhibitors, black bars). The number of cell colonies are represented on the Y axis. After treatment
with Jaki for 15 days the FGF-iPSCs maintein the morphology (B) and the Oct4-GFP expression (C). (D-E) AP staining reveal the mainteinance of
positive colonies in treated cells. (F) After treatment the cells show no X chromosome inactivation. (G) Western blot show the expression of Stat3 and
P-Stat3 in FGF-iPSCs and mESC. Stat3 phosphorylation is suppressed by Jaki. (H) Gene expression analysis by qPCR among mESCs, FGF-iPSCs, EpiSCs,
FGF-iPSCs + Jaki and FGF-iPSCs + alphaLIF.
doi:10.1371/journal.pone.0016092.g006
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endpoint that is achieved independent of the culture growth factor
conditions. Several lines of evidence make it highly unlikely that
the ES cell pluripotent state is the result of low-level residual LIF
activity emerging from the MEF feeders. First, FGF-iPS cells can
be maintained under defined culture conditions in the absence of
MEF feeders. Second, the FGF-derived iPS cells are dependent on
bFGF signaling for their continued self-renewal, and are not
affected by prolonged inhibition of JAK-STAT signaling. Finally,
switching the cells to conventional mES culture conditions with
addition of LIF results in FGF-iPSC differentiation, indicating that
LIF is in fact incapable of maintaining FGF-iPS cells.
FGF-iPSCs and standard ESCs or iPSCs do not represent
alternative metastable cell states as described for ESCs and
EpiSCs, but cells with similar properties sharing an equivalent
pluripotency state. Consistent with this, while EpiSCs require the
stable exogenous expression of Klf4 or c-Myc for their conversion
into conventional ESCs or, alternatively, the presence of small
molecules that can replace these factors during reprogramming
[4,17], FGF-iPSCs can be converted to conventional LIF-
dependent iPSCs by simply switching growth factor culture
conditions. A similar approach was shown to efficiently induce
the conversion of epiblast cells from the primitive ectoderm into
ES-cell-like cells (rESCs) [16]. Using an ESC-specific Oct4 distal
enhancer reporter cell line, Bao and colleagues demonstrated that
approx. 22–36% of epiblast cells respond to a switch in growth
factors from FGF to LIF by upregulating the ESC-specific GFP
reporter [16]. This efficiency in rESC derivation is much higher
than the conversion rate we observed between FGF-iPSCs and
LIF-dependent ESCs, indicating a relative more robust epigenetic
barrier exists between these two cell types. However, when the
same switch was applied to established EpiSC, the efficiency for
generating rESCs was extremely more reduced and therefore
more similar to what described in our experimental conditions.
Iinhibition of Erk signalling, either by BMP4-induced upregula-
tion of ID proteins or using small molecule inhibitors, is required
in mESCs to maintain the ICM-like pluripotent state [18]. It is
striking that FGF-dependent iPSCs maintain a naive pluripotent
state in the presence of strong ERK activity. The morphological
and epigenetic similarities between murine EpiSCs and human
ESCs suggest that human ESCs, despite their blastocyst origin,
exist in a primed pluripotent state. Our data now demonstrate that
a naive pluripotent state can be achieved in FGF-dependent
murine iPSCs. Revealing the molecular mechanisms that install a
naive pluripotent state in FGF-iPSCs may provide important cues
the identity of human ESCs.
Hanna and colleagues recently demonstrated that in the non-
permissive NOD genetic background, the ES-like pluripotent state
is metastable, and remains dependent on the ectopic expression of
Klf4 or cMyc or the presence of small molecule inhibitors of GSK3b
or the MEK-ERK signaling pathway. In this genetic background,
the EpiSC pluripotent state appears dominantly stable and is
achieved upon withdrawal of ectopic reprogramming factors. Our
results demonstrate that the opposite is true for ‘permissive’ mouse
strains such as the 129Sv, C57B/L6 and 129/BL6 F1 genetic
backgrounds used in this study. The genetic elements that allow the
derivation of ES-cell lines in these strains may be the same that
dominantly stabilize the ES-like pluripotent state in iPS cells from
these strains. The murine ES-like state offers several functional
Figure 7. Feeder-free culture of FGF-iPSCs. The FGF-iPSCs growth in the absence of feeder layer as colonies expressing Oct4-GFP (A–B). (C–D)
The colonies are positive for alkaline phophatase. (E–G) FGF-iPSCs maintain the expression of Nanog in a feeder free condition. (H) Staining for H3K27
on FGF-iPS colonies show the absence of X-chromosome inactivation.
doi:10.1371/journal.pone.0016092.g007
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advantages over the epiblast-stem cell state, since it allows ready
manipulation of the genome combined with the ability to generate
chimeras. While gene targeting is commonplace in some mouse
strains, other species do not readily allow gene manipulation using
similar experimental approaches, since in most species the primed
pluripotent state appears to prevail. Primed pluripotent stem cells
are refractive to single cell culture, which severely hampers the
clonal derivation of mutant cell lines. In addition, the murine ES-
state allows the generation of chimeras and may thus facilitate the
generation of animal mutants to model human disease in alternative
species. Indeed, the recent derivation of rat pluripotent stem cells in
a murine ES-like state illustrates this point [9,10].
Understanding the nature of the genetic factors that dominantly
stabilize the murine ES-like pluripotent state and uncovering their
function in the stabilization of the ES-like pluripotent state is
fundamentally important to understanding how to harness the power
of this pluripotent state in future research and cell based therapies.
Materials and Methods
Ethics Statement
Animal care and experimental procedures were performed in
accordance with ‘‘Decreto Legislativo n. 116 del 27 Gennaio
1992’’ and with the Institutional Committee for the Good Animal
Experimentation of the San Raffaele Scientific Institute (IACUC
423).
This study was performed following ethical approval by the
institutional review board of San Raffaele Scientific Institute.
Culture of murine ES cells, EpiSCs and iPSCs
Murine ES (Di Stefano et al., 2009) and LIF-iPS cells (Di
Stefano et al., 2009) were cultured on feeder layer in ES medium
composed by knock-out DMEM medium (Invitrogen) containing
15% fetal bovine serum (Invitrogen), leukemia inhibitor factor
(LIF) (Chemicon), 2-b-mercaptoethanol, L-glutamine and non-
essential amino acids (Invitrogen) as detailed in Di Stefano et al.
(2009). FGF-iPS cells were cultivated on mytomicin-inactivated
MEF in human ESC medium containing knock-out DMEM
medium (Invitrogen) containing 20% knock-out serum replace-
ment (Invitrogen), 4 ng/ml bFGF (Peprotrech), 2-b-mercaptoeth-
anol, L-glutamine and non-essential amino acids (Invitrogen).
FGF-iPSCs were normally passaged in small clumps after
treatment with collagenase IV (1 mg/ml) every 3 to 5 days in
average. LIF-iPS, EpiSC and FGF-iPScells were cultured on
Matrigel-coated dishes for two passages for depletion of feeder cells
Figure 8. In vitro and in vivo pluripotency of FGF-iPSCs. (A) FGF-iPSCs were detached with collagenase IV from the substrate to induce embryoid
body (EB) formation. After 5 days in culture, the majority of EBs downregulate the GFP transgene. (B) EBs plated in N2-medium generate nestin positive
neural progenitor cells as highlighted by immunofluorescence with its specific antibody. (C) EBs were plated on gelatin coated dishes containing DMEM
medium supplemented with 20% FBS. After 20 days in such condition, islands of beating cardiomyocite became evident (see Movie S1). Cell
differentiation was confirmed by immunoistochemistry for the mesodermal marker smoothmuscle actin (Sma) (C) and for the endodermal marker Sox17
(D). (E–H) Ematoxylin and Eosin histological staining of teratomas, derived by subcutaneously injection of 1 million FGF-iPSCs, showed cartilage (E),
adipose tissue (F), gut-like epithelium (G) and muscle (H). (I) Oct4-GFP positive FGF-iPSCs integrate into the inner cell mass of mouse blastocyst after
morula aggregation and contribute, thereafter, to viable highly chimaeric animals (on the right) as compared to unmanipulated mice (on the left) (J). (K)
Germiline contribution of FGF-iPS #5 and #9 chimera. (L) Genotyping demontrate the presence of the Oct4-GFP transgene in the offspring.
doi:10.1371/journal.pone.0016092.g008
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before DNA and RNA isolation. EpiSC [19] were maintained in
the same conditions of FGF-iPS.
Derivation of iPS cells using retroviral vectors
Oct4-GFP embryonic or post-natal fibroblasts were obtained
from the OG2 transgenic mouse line kindly provided to us by Dr.
Michele Boiani (Max Planck Institute, Mu¨nster, Germany). Briefly,
E15.5 transgenic embryos were isolated, washed repetitively in PBS
and then the heads and all the visceral tissues dissected out. The
remaining carcasses were washed, minced and dissociated after a
trypsin treatment of 309 at 37uC. Single cells and small aggregates
were cultured and propagated in DMEMmedium (Invitrogen) with
10% FBS (Sigma). For post-natal fibroblasts, clipped tails were
rinsed in PBS supplemented with antibiotics and careful minced,
before digestion into trypsin for 209 at 37uC. Digested tissue was
finely disaggregated with Pasteur pipettes and single cell suspension
plated and propagated in DMEM medium (Invitrogen) with 10%
FBS (Sigma). For induction of FGF-iPS cells, 200.000 MEFs were
seeded onto gelatin-coated dishes in DMEM medium with 10%
serum and transduced by pLIB-based retroviruses for mouse Oct4,
Klf4, Sox2 and c-Myc. Two days after, the cells were harvested and
replated on mytomicin-inactivated MEF in 100 mm dish and
incubated in human ESC medium. After 15–17 days (for O-S-K-M
transduced cells) or 21–23 days (for O-S-K/O-S-M), the FGF-iPS
colonies were picked for expansion on MEF feeder cells in human
ESCmedium. A schematic diagram of the reprogramming protocol
used is shown in Figure 1A. Retroviral production was performed as
described before [6]. Briefly, Murine cDNAs for Oct4, Klf4, Sox2
and c-Myc were amlified by PCR from ES cells cDNA and cloned
into Moloney-based retroviral vector pLIB (kindly donated by Dr.
Marius Wernig, Stanford University, CA). Plat-E cells were plated
at 46106 cells per 100 mm dish and incubated overnight. Cells were
transfected with 10 mg of vector, according to a conventional CaCl2
transfection protocol. After 30 h, medium was collected, filtered
through 0.44 mm cellulose acetate filters and supplemented with
4 mg/ml Polybrene (Sigma). MEFs were then exposed to viral-
polybrene containing supernatants.
Derivation of iPS cells using STEMCCA vectors
Fibroblasts were harvested from tails of Oct4-GFP/R26-
M2rtTA transgenic newborn mice and maintained in DMEM
with 10% FBS, 2 mM L-Glutamine and Pen/Strep (all Invitro-
gen). To produce infectious viral particles, 293 T cells cultured on
10 cm dishes were transfected with the STEMCCA vectors
together with the packaging plasmids VSV-G and D8.9 using
Lipofectamine2000 (Invitrogen). The fibroblasts were transduced
at ,4000 cells/cm2 on 10 cm TC dishes with concentrated virus.
The transgenes were induced the following day by adding 2 ug/ml
Doxycyline (Sigma) to the media. After one more day cells were
split onto two new 10 cm dishes and the media was changed to ES
or human ESC media. Doxycyline was removed after 15 days and
colonies were picked after 3 to 5 more days and maintained as
described above.
Alkaline phosphatase, immunofluorescence assay and
FISH
For alkaline phosphatase (AP) staining, cells were fixed with 2%
paraformaldehyde for 10 min at RT, washed two times with PBS
(Euroclone) and treated with AP solution containing BCIP and
NBT (Roche). For immunocytochemistry, cells were fixed with 4%
paraformaldehyde for 20 min at RT and washed three times with
PBS (Euroclone). Fixed cells were then incubated in blocking
buffer containing 5% goat serum (Sigma) and 0,1% Triton X-100
for 30 minutes at RT. The cells were then incubated with primary
antibodies diluted in the blocking buffer overnight at 4uC. On the
next day, after 3 washes in PBS, the cells were exposed to
secondary antibodies at RT for one hour. Primary antibodies
included SSEA1 (1:100, Chemicon), Desmin (1:200, kindly
donated by G.Cossu), SMA (1:200, kindly donated by L. Naldini),
Nanog (1:100, Abcam), Oct4 (1:100, Abcam), Sox2 (1:100,
Abcam), me3H3K27 (1:100, kindly donated by G. Testa).
Secondary antibodies used were donkey anti-mouse and anti-
rabbit IgG and IgM antibodies conjugated with Alexa 488, Alexa
594 (1:500, Molecular Probes). Nuclear staining was performed
with Hoechst 33342 (Invitrogen). Pictures were taken using a
Nikon Eclipse 3000 fluorescence microscope.
For RNA FISH the Xist probe used a 19 kb genomic fragment
derived from a lamda clone which covers most of Xist gene. Probes
were labeled by nick translation with Spectrum Green-dUTP and
hybridized (0.1 ug of probe DNAwith 10 ug of salmon spermDNA
per coverslip) in 50% formamide, 2 x SSC, 20% dextran sulfate,
1 mg/ml BSA (Biolabs), and 200 mM VRC, overnight at 37uC.
After three washes in 50% formamide, 2 x SSC and three washes in
2 x SSC at 42uC, DNA was counterstained for 3 min in 0.2 mg/ml
DAPI, followed by a final wash in 2 x SSC. Samples were mounted
in 90% glycerol, 0.1x PBS, 0.1% p- phenylenediamine.
Feeder-free culture of FGF-iPSCs
FGF-iPS cells were cultivated on fibronectin (Sigma) coated
dishes (5 ug/ml) in a knock-out DMEM medium (Invitrogen)
containing N2 and B27 and supplemented with 100 ng/ml bFGF
(Invitrogen), 50 ng/ml ActivinA (Peprotech), 2-b-mercaptoetha-
nol, L-glutamine and non-essential amino acids (Invitrogen).
RT-PCR analysis
The RNeasy mini-kit (Qiagen) was used for total RNA isolation
and Superscript reverse transcriptase II (Invitrogen) for cDNA
synthesis starting with 2 mg of total RNA. Amplification of specific
genes was carried out using primers shown in Table S1. PCR
conditions were as follows: 95uC for 10 minutes; denaturation at
95uC for 30 sec, annealing for 30 sec at a temperature specific for
each primer set, and extension at 72uC for 30 sec for 33 cycles and
then 72uC for 10 minutes.
Luciferase reporter assay
Plasmids for the Oct4 enhancer assay were cloned as described
[2]. 12 well plates with mES, EpiSCs and FGF-iPS cells were
transfected with the 1 ug of the respective Oct4 enhancer plasmid
and 0.1 ug of a renilla control plasmid using Lipofectamine2000
(Invitrogen). Luciferase activity was measured using the Dual
Luciferase Reporter Assay System (Promega) following the
manufacturer’s protocol. All experiments were carried out in
triplicates and normalized to renilla activity to account for
differences in transfection efficiencies.
Agilent chip hybridization
For genome-wide expression analysis, total RNA was extracted
using Trizol reagent (Invitrogen) and labeled and hybridized to
Agilent Whole Mouse Genome Oligo 4X44K Microarrays (one-
color platform) according to the manufacturer’s protocols. The
gene expression results were analyzed using GeneSifter microarray
analysis software.
Illumina bead chip hybridization
Biotin-labelled cRNA was produced using a linear ampLIFica-
tion kit (Ambion, Austin, TX, United States). Total RNA was
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quality-checked by NanoDrop analysis (NanoDrop Technologies,
Wilmington, DE, USA) and a quantity of 400 ng was used as
input. Chip hybridization, washing, Cy3-streptavidin staining and
scanning were performed on the Illumina BeadStation 500
platform (Illumina, San Diego, CA, United States), according to
manufacturer’s instruction. cRNA samples were hybridized onto
Illumina mouse-8 BeadChips. We hybridized the following
samples as biological replicates: ESCs, LIF-iPSCs and FGF-iPSCs.
All basic expression data analysis was carried out using the
BeadStudio software 3.0. Raw data were background-subtracted
and normalized using the ‘‘rank invariant’’ algorithm and then
filtered for significant expression on the basis of negative control
beads. Pathway analysis was determined according to Gene
Ontology terms or mapped to Kegg pathways using DAVID 2006
(http://david.abcc.ncifcrf.gov) by using GenBank accession num-
bers represented by the corresponding chip oligonucleotides as
input. Analysis of the transcriptional regulatory circuit was
performed using String database 8.0 (http://string.embl.de/).
Real-time polymerase chain reaction (qPCR)
Real-Time PCR was performed in 384 Well Optical Reaction
Plates (Applied Biosystems, Foster City, CA, United States). The
PCR mix in each well included 5 ml of SYBRHGreen PCR Master
Mix (Applied Biosystems), 1.5 ml each of the forward and reverse
primers (5 ng/ml) and 1 ml of single strand cDNA (50 ng/ml) in a
final reaction volume of 10 ml. qPCR reactions were carried out
on the ABI PRISM 7900HT Sequence Detection System (Applied
Biosystems) using the following program: 50uC for 2 min, 95uC for
10 min, 95uC for 15 s and 60uC for 1 min, 95uC for 15 s, 60uC
for 15 s and 95uC for 15 s for a total of 40 cycles. Triplicate
amplifications were carried out for each target gene with three
wells serving as negative controls. The output data generated by
the Sequence Detection System software were transferred to
Microsoft Excel for analysis. Quantification was performed
through a standard curve-based method and normalized to the
expression of the housekeeping gene beta-actin. Primer sequences
are provided in Table S1.
Western blotting
Protein extracts were isolated from ESCs, LIF-iPSCs and FGF-
iPSCs using a modified RIPA buffer lysis buffer (150 mM NaCl,
10 mM Tris-HCl, 1 mM EDTA, 1% Triton-X100; pH 7.8)
supplemented with complete protease inhibitor cocktail (Sigma)
added just before use. Protein concentration was determined
according to the Bradford method. Equal quantities of proteins
were separated by electrophoresis in a 10% SDS-polyacrylamide
gel (BioRad, Hercules, CA). Primary antibodies, purchased from
Cell Signalling Technology, against SMAD 2/3, Phospho-SMAD
2/3, SMAD 1/5/8, Phospho-SMAD 1/5/8, ERK K, phospho-
ERK K, Stat3 and phospho-Stat3 were used with the suitable
HRP-conjugated secondary antibodies. Bound antibodies on
nitrocellulose membrane (Amersham Biosciences) were then
detected using the chemiluminescent substrate ECL (Amersham
Biosciences).
Methylation analysis
Methylation analysis was performed as previously described by
Blelloch et al. (2006). Genomic DNA extraction was performed
using the Blood & Cell Culture DNA Mini Kit (Qiagen). Bisulfite
treatment of DNA was achieved using the CpGenome DNA
Modification Kit (Chemicon) according to the manufacturer’s
instructions. The resulting modified DNA was ampLIFied by
nested polymerase chain reaction (PCR) using two forward (Met-
Oct4 F1 and Met-Oct4 F2) primers and one reverse (Met-Oct4 R)
primer listed in Table S1.The first round of PCR was done as
follows: 94uC for 4 minutes; five cycles of 94uC for 30 seconds,
56uC for 1 minute (–1uC per cycle), 72uC for 1 minute; and 30
cycles of 94uC for 30 seconds, 51uC for 45 seconds, and 72uC for 1
minute, 20 seconds. The second round of PCR was 94uC for 4
minutes; 30 cycles of 94uC for 30 seconds, 53.5uC for 1 minute,
and 72uC for 1 minute 20 seconds. The resulting ampLIFied
products were gel-purified (Promega), subcloned into the TA
vector (Invitrogen), and sequenced using the T7 and SP6 primers.
Small-molecule compounds
The following inhibitors were used at the indicated final
concentrations: ALK inhibitor (A8301, Tocris Bioscience; 0.5 mM)
and JAK inhibitor I (Calbiochem 420099; 0.6 mM), SU5402
(Calbiochem 572630, 10 mM). Anti-mouse LIF antibody was
purchased by R&D system.
Teratoma formation
One million of serially passaged FGF-iPS cells were harvested
by collagenase IV treatment, diluted in DMEM/F12 and injected
subcutaneously into the hind limb muscle of SCID mice. Five to six
weeks after the injection all mice developed tumors. Teratomas
were removed, fixed overnight in 4% PFA and embedded in
Paraffin. 10 um thicken sections were stained with hematoxylin
and eosin for conventional morphological assessment.
Differentiation of FGF-iPS cells
For EB formation, FGF-iPS cells were harvested by treating
with 1 mg/ml collagenase IV for one hour. The clumps of cells
were then transferred into T25 flasks for 6 days in differentiation
medium (knock-out DMEM containing 20% knock-out serum
replacement, 2-b-mercaptoethanol, L-glutamine, penicillin-strep-
tomycin and non-essential amino acids). For the generation of
cardiomyocytes and Sox17-positive cells, EBs were plated onto
gelatin-coated tissue culture dishes at very low density in DMEM
medium with 20% animal serum. Medium was replaced every two
days. For neural differentiation EBs were cultured for 6 days in
differentiation medium and then plated onto matrigel coated
dishes in N2-medium.
Chimera production
Morulas were collected from the oviduct of superovulated CD-1
females mated with CD-1 males 48 hrs earlier by a flushing
procedure with BMOC-3 medium. The zona pellucida was
removed from the embryos by washing through 3 consecutive
drops of Acid Tyrode solution (Sigma). Small clumps of FGF-cells
were generated after treatment with collagenase IV. One clump
containing between 5 to 15 FGF-iPS cells was added to each
embryo and cultured in BMOC-3 medium (Invitrogen) overnight
at 37uC 5% in 5% CO(2). The following day, embryos, which had
developed into blastocysts, were transferred into the uterus of
pseudopregnant recipient CD-1 females mated with vasectomized
CD-1 males 2.5 days earlier.
Supporting Information
Figure S1 Epigenetic, transgene silencing and chromo-
some stability of FGF-iPSCs. (A) Scheme representing the
methylation pattern of the Oct4 promoter in FGF-iPSCs (line 5C)
and MEFs. Open circles indicate unmethylated, while filled circles
depict methylated CpG dinucleotides. All the CpG dinucleotides
tested were unmethylated in FGF-iPSCs. (B) Silencing of retroviral
expressed transgenes was assessed by qPCR analysis. (C) A
chromosome spread of FGF-iPS cells is presented with a normal
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number of chromosomes (2n= 40). (D) Luciferase reporter assay of
Oct4 enhancer usage in murine ES cells, EpiSCs, LIF-derived iPS
cells and FGF-derived iPS cells as indicated.
(TIF)
Figure S2 Reprogramming by lentiviral inducible
transduction. (A) Schematic representation of the strategy used
for the reprogramming of murine fibroblasts into iPS cells in the
presence of LIF or bFGF. (B) Image of an EpiSC-like iPS cell
colony derived in bFGF.
(TIF)
Figure S3 Effect of FGF withdrawal on FGF-iPSCs. In the
absence of bFGF (B) or in the presence of a specific FGFR
inhibitor (SU5402) (C), FGF-iPSCs differentiate extensively.
(TIF)
Figure S4 Facile conversion of FGF-iPSCs to LIF
supplemented culture conditions. (A–D) After stimulation
in a medium containing LIF, FGF-iPSCs assume a close ES-like
morphology and adapt to these new conditions growing as
homogeneous colonies over time (10 passages, for 3 months in
culture). We termed these cells as LIF-stimulated FGF-iPSCs.
When these cells were returned back to the original FGF medium
and cultured for another week, they acquired the original
morphological characteristic (reverted FGF-iPSCs) (E, F). A, C,
E, Cell colonies in bright-field. B, D, F, GFP expression controlled
by the Oct4 promoter (OG2 transgenic cells).
(TIF)
Figure S5 Expression analysis on Dlk1-Dio locus. (A–B)
Expression of Glt2 and Dlk1 locus in ES cells, FGF-iPS cells and
EpiSC cells. The analysis reveal that in at least one FGF-iPSC
clone the expression of Gtl2 is correct.
(TIF)
Movie S1 Beating cardiomyocytes derived from in vitro
differentiation of FGF-iPSCs.
(MPG)
Table S1 List of the primers used for RT-PCR, qPCRs
and genomic methylation analysis.
(DOC)
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